Fangli Ma

Fangli Ma


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JZJu Zhang
Ju Zhang
RSRuona Shi
Ruona Shi
HLHaifeng Li
Haifeng Li
YXYanxia Xiang
Yanxia Xiang
LXLingyun Xiao
Lingyun Xiao
ZHZebo Huang
Zebo Huang

10 June 2014 in Molecules
Verified
Journal Article
Open access
PDF file
LXLingyun Xiao
Lingyun Xiao
HLHaifeng Li
Haifeng Li
JZJu Zhang
Ju Zhang
FYFan Yang
Fan Yang
AHAizhen Huang
Aizhen Huang
ZHZebo Huang
Zebo Huang
Polyglutamine (polyQ) aggregation plays a pivotal role in the pathological process of Huntington’s disease and other polyQ disorders. Therefore, strategies aiming at restoring dysfunction and reducing stresses mediated by polyQ toxicity are of therapeutic interest for proteotoxicity diseases. Salidroside, a glycoside from Rhodiola rosea, has been shown to have a variety of bioactivities, including antioxidant activity. Using transgenic Caenorhabditis elegans models, we show here that salidroside is able to reduce neuronal death and behavioral dysfunction mediated by polyQ expressed in ASH neurons, but the neuroprotective effect is not associated with prevention of polyQ aggregation per se. Further experiments reveal that the neuroprotective effect of salidroside in C. elegans models involves its antioxidant capabilities, including decrease of ROS levels and paraquat-induced mortality, increase of antioxidant enzyme activities and reduction of lipid peroxidation. These results demonstrate that salidroside exerts its neuroprotective function against polyQ toxicity via oxidative stress pathways.

1 January 2016 in Food & Nutrition Research
Verified
Journal Article
Open access
PDF file
WZWei K Zhang
Wei K Zhang
STShan-Shan Tao
Shan-Shan Tao
TLTing-Ting Li
Ting-Ting Li
YLYu-Sang Li
Yu-Sang Li
XLXiao-Jun Li
Xiao-Jun Li
CWChu-Jun Wan
Chu-Jun Wan
Nutmeg oil alleviates chronic inflammatory pain through inhibition of COX-2 expression and substance P release in vivo

23 January 2018 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
MCMingyi Chen
Mingyi Chen
BLBiyu Lu
Biyu Lu
YLYuan Li
Yuan Li
YWYuanyuan Wang
Yuanyuan Wang
HZHaihui Zheng
Haihui Zheng
ZXZhiyong Xie
Zhiyong Xie
Polysaccharides can alleviate obesity in mammals; however, studies on mechanism of this alleviation are limited. A few studies have indicated that polysaccharides improve obesity by regulating the metabolism of the body. Therefore, a metabolomics approach, consisting of high resolution nuclear magnetic resonance (NMR) spectroscopy and a multivariate statistical technique, was applied to explore the mechanism of the protective effects of lentinan and Flos Lonicera polysaccharides (LF) on high-fat diet (HFD) induced obesity. In this study, rats were randomly divided into three groups: control diet (CD), HFD, and HFD supplemented with a mixture of lentinan and Flos Lonicera polysaccharide. Histopathological and clinical biochemical assessments were also conducted. A combination of a NMR metabolomics study and a multivariable statistical analysis method to distinguish urinary and fecal metabolites was applied. Significant obesity symptoms appeared in HFD rats (for example, significant weight gain, epididymal adipose accumulation and lipid deposition in hepatocytes), which was attenuated in the LF group. Additionally, the HFD induced a reduction of choline, citrate, pyruvate and glycerol and increased the levels of trimethylamine oxide (TMAO) and taurine. Of note, these metabolic disorders were reversed by LF intervention mainly through pathways of energy metabolism, choline metabolism and gut microbiota metabolism. LF supplementation had a re-balancing effect on the disturbed metabolic pathways in the obese body. The results of this study validate the therapeutic effect of the compound polysaccharide--LF in obesity and described the biochemical and metabolic mechanisms involved.

15 June 2021 in Beneficial Microbes
Verified
Journal Article
Closed access
GWG. Wang
G. Wang
GZG. Zhu
G. Zhu
CCC. Chen
C. Chen
YZY. Zheng
Y. Zheng
FMFangli Ma
Fangli Ma
WCW. Chen
W. Chen
Regulation on gut microbiota and short-chain fatty acids (SCFAs) are believed to be a pathway to suppress the development of metabolic syndrome. In this study, three Lactobacillus strains derived from the human gut were investigated for their effects on alleviation of metabolic disorders. These strains were individually administered to metabolic disorder rats induced by high-fat-high-sucrose (HFHS) diet. Each strain exhibited its own characteristics in attenuating the impaired glucose-insulin homeostasis, hepatic oxidative damage and steatosis. Correlation analysis between SCFAs and host metabolic parameters suggested that Lactobacillus protective effects on metabolic disorders are partly mediated by recovery of SCFAs production, especially the faecal acetic acid. Correspondingly, it indicated that probiotics restore the gut microbiota dysbiosis in different extent, thereby protect against metabolic disorders in a manner that is associated with microbiota, but not totally reverse the changed composition of microbiota to the normal state. Thus, Lactobacillus strains partly protect against diet-induced metabolic syndrome by microbiota modulation and acetate elevation.

1 January 2019 in Chemistry and Physics of Lipids
Verified
Journal Article
Closed access
YGYuan Gao
Yuan Gao
SWShimin Wu
Shimin Wu
RCRenhuai Cong
Renhuai Cong
JXJunyong Xiao
Junyong Xiao
FMFangli Ma
Fangli Ma